| Neurotrophic tyrosine receptor kinase (ntrk) degrading compounds |
2022-9-29 |
2023-4-06 |
|
| Selected compounds for targeted degradation of BRD9 |
2022-9-09 |
2023-3-17 |
|
| Selected compounds for targeted degradation of brd9 |
2022-9-09 |
2023-3-09 |
|
| Compounds for targeted degradation of brd9 |
2022-9-01 |
2023-3-02 |
|
| Compounds for targeting degradation of irak4 proteins |
2022-7-07 |
2023-1-12 |
|
| Compounds for targeting degradation of irak4 proteins |
2022-7-07 |
2023-1-12 |
|
| Isoindolinone and indazole compounds for epidermal growth factor receptor (egfr … |
2022-6-17 |
2022-7-08 |
|
| Isoindolinone and indazole compounds for the degradation of egfr |
2022-6-17 |
2023-4-13 |
|
| Therapeutics for the degradation of mutant braf |
2022-6-08 |
2023-2-23 |
|
| Egfr degraders to treat cancer metastasis to the brain or cns |
2022-5-26 |
2022-12-01 |
|
| Compounds for targeting degradation of bruton's tyrosine kinase |
2022-5-05 |
2022-11-10 |
|
| Tricyclic degraders of ikaros and aiolos |
2022-4-18 |
2023-3-16 |
|
| Tunable endogenous protein degradation |
2022-1-20 |
2022-5-05 |
|
| Dihydrobenzimidazolones for medical treatment |
2022-1-14 |
2022-9-15 |
|
| Spirocyclic degronimers for target protein degradation |
2021-11-11 |
2023-3-30 |
|
| Tricyclic ligands for degradation of ikzf2 or ikzf4 |
2021-10-14 |
2022-4-21 |
|
| Tricyclic compounds to degrade neosubstrates for medical therapy |
2021-10-14 |
2022-4-21 |
|
| Tricyclic heterobifunctional compounds for degradation of targeted proteins |
2021-10-14 |
2022-4-21 |
|
| Heterocyclic compounds for medical treatment |
2021-9-02 |
2023-1-19 |
|
| Advantageous therapies for disorders mediated by Ikaros or Aiolos |
2021-8-06 |
2023-4-13 |
|
| ADVANTAGE THERAPIES FOR DISORDERS MEDIATED BY IKAROS OR AIOLOS |
2021-8-06 |
2022-11-02 |
|
| Advantageous therapies for disorders mediated by ikaros or aiolos |
2021-8-06 |
2022-6-01 |
|
| Compounds for targeted degradation of ret |
2021-8-05 |
2022-2-10 |
|
| Targeted protein degradation |
2021-6-18 |
2022-11-24 |
|
| Heterobifunctional compounds as degraders of braf |
2021-6-18 |
2021-12-23 |
|
| Braf degraders |
2021-6-18 |
2021-12-23 |
|
| BRAF DEGRADERS |
2021-6-18 |
2022-9-28 |
|
| COMPOUNDS FOR THE TARGETED DEGRADATION OF BRD9 |
2021-3-05 |
2022-6-08 |
|
| Compounds for the degradation of brd9 or mth1 |
2021-3-04 |
2021-7-01 |
|
| Heterocyclic degronimers for target protein degradation |
2021-2-01 |
2023-1-19 |
|
| ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR EGFR DEGRADATION |
2020-12-21 |
2022-3-23 |
|
| Substituted piperidine degronimers for target protein degradation |
2020-12-14 |
2022-10-06 |
|
| C3-carbon linked glutarimide degronimers for target protein degradation |
2020-11-30 |
2022-10-06 |
|
| Compounds |
2020-11-25 |
2021-3-18 |
|
| Spirocyclic compounds |
2020-11-24 |
2023-4-11 |
2023-4-11 |
| Spirocyclic compounds |
2020-11-24 |
2021-3-11 |
|
| Bifunctional compounds for the treatment of cancer |
2020-10-28 |
2022-9-07 |
|
| Bifunctional compounds |
2020-10-26 |
2022-6-07 |
|
| Spirocyclic compounds |
2020-10-16 |
2021-2-04 |
|
| Cereblon binders for the degradation of ikaros |
2020-9-24 |
2021-1-14 |
|
| Bifunctional molecules that degrade egfr |
2020-8-04 |
2020-11-19 |
|
| Bifunctional inhibitors with egfr having a e3 ubiquitin ligase moiety |
2020-6-16 |
2020-10-01 |
|
| Degraders and degrons for targeted protein degradation |
2020-5-14 |
2022-8-11 |
|
| Glutarimides for medical treatment |
2020-3-04 |
2020-7-02 |
|
| Dihydroquinolinones for medical treatment |
2020-3-04 |
2020-7-02 |
|
| N/o-linked degrons and degronimers for protein degradation |
2019-12-19 |
2020-5-07 |
|
| Substituted isoindole allosteric egfr inhibitors,pharmaceutical compositions … |
2019-11-28 |
2022-10-01 |
|
| HSPC-sparing treatments for RB-positive abnormal cellular proliferation |
2018-11-01 |
2021-2-23 |
2021-2-23 |
| Compounds |
2018-6-01 |
2018-12-06 |
|
| Regulating chimeric antigen receptors |
2018-2-08 |
2022-4-26 |
2022-4-26 |
| Tunable endogenous protein degradation with heterobifunctional compounds |
2018-2-08 |
2019-12-12 |
|
| 2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds |
2017-12-21 |
2018-6-28 |
|
| Bromodomain targeting degronimers for target protein degradation |
2017-5-10 |
2017-11-16 |
|
| Composés de dégradation de kinase du récepteur de la tyrosine neurotrophique ( … |
2022-9-29 |
2023-4-06 |
|